Orforglipron, a new pill-form GLP-1 drug, performed better than oral semaglutide in clinical trials for blood sugar control and weight loss. However, the medication may cause more side effects than current options, and it's easier to manufacture and store than existing treatments.
Posts tagged as “new research”
A comprehensive review of research studies suggests that GLP-1 medications like Ozempic and Wegovy might reduce the protein buildup associated with Alzheimer's disease.
A long-term study following over 100,000 people for three decades found that doing a variety of physical activities significantly lowers the risk of death compared to sticking with the same type of exercise.
New studies suggest tirzepatide, a popular weight loss medication, may help prevent heart disease in people at high risk. This adds to the growing list of health benefits beyond weight loss for GLP-1 drugs like tirzepatide.
Research reveals that regular, high-quality sleep can extend your lifespan by up to four years. Sleep experts share proven strategies and hacks for achieving better rest and addressing common sleep disruptors like nighttime anxiety.
A new study reveals that surprisingly small amounts of vigorous activity can unlock major health benefits and help you live longer. Just five minutes of high-intensity exercise per day could reshape how you approach training.
Researchers found that climbing stairs for just 20 seconds, three times a day for six weeks, improved participants' heart and lung fitness by 5-7%. These short bursts of activity, called 'exercise snacks,' could provide significant health benefits even with minimal time commitment.
New research reveals that about 10% of people may have 'GLP-1 resistance' due to specific genetic variants, making drugs like Ozempic and Wegovy less effective. These individuals appear to produce higher levels of certain compounds that interfere with the medication's effectiveness.